한빛사논문
Bokyung Min1,2,3, Bitna Yang2, You-Sun Kim2, Gyeong Min Park2, HyunAh Kim2, Hyojin Kim2, Eun-Ji Kim2, Yu Kyeong Hwang2, Eui-Cheol Shin1,3,4,* and Sungyoo Cho2,4,*
1BioMedical Science and Engineering Interdisciplinary Program, KAIST, Daejeon, Korea. 2Cell Therapy Research Center, GC LabCell, Yongin, Korea. 3Laboratory of Immunology and Infectious Diseases, Graduate School of Medical Science and Engineering, KAIST, Daejeon, Korea. 4These authors contributed equally: Eui-Cheol Shin, Sungyoo Cho.
*Correspondence to Eui-Cheol Shin or Sungyoo Cho.
Abstract
Natural killer (NK) cells play an important role in the antitumor immune response as the major cytotoxic lymphocytes in the innate immune system. NK cells without any genetic modifications have been used for both autologous and allogeneic therapies. Moreover, many reports have suggested that allogeneic NK cells can reduce the recurrence of disease and improve survival through a graft-versus-leukemia effect without GVHD [1, 2].
논문정보
관련 링크
연구자 키워드
연구자 ID
관련분야 연구자보기
소속기관 논문보기
관련분야 논문보기
해당논문 저자보기